Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences is a U.S.-based special purpose acquisition company formed to identify and combine with a business in the life sciences sector. As a blank-check company, it does not operate a commercial product business itself; instead, it holds IPO proceeds in trust while searching for a target acquisition.

1.19

1.19

— Oaktree Acquisition Corp. III Life Sciences
%
SPAC vehicle100% Capital-raising shell company formed to complete a future business combination.

The company does not sell products or services to end customers in the ordinary course...

  • Public shareholdersprimary

    Invest in the SPAC units and shares for exposure to a future acquisition transaction.

  • Sponsor and affiliatesprimary

    Provide private placement capital, administrative services, and transaction support.

  • Future acquisition targetprimary

    A life sciences company that may merge with the SPAC to access public markets.

  • Underwriterssecondary

    Facilitate the IPO and earn underwriting fees tied to the capital raise.

The company is incorporated and headquartered in the United States, and its securities are issued through U.S...

  • •United States is the corporate and capital-markets base
  • •No operating revenue geography is disclosed because it has no operations
  • •Future geography will depend on the acquired life sciences business
  • •Current activity is centered on U.S. listing and trust-account management

The company’s strategy is to identify and complete a business combination with a life sciences target within its...

01
Complete a business combinationshort-term

The SPAC has no operating business until it merges with a target.

02
Manage liquidity and working capitalshort-term

Public-company and transaction costs continue before any merger closes.

03
Preserve shareholder value through structuremedium-term

Redemptions and trust-account mechanics affect the capital available for a deal.

The main risk is that the company may fail to complete a business combination before its deadline, which could force...

critical

Business combination deadline risk

If no transaction closes by the deadline, the company may liquidate and dissolve.

Scope
All shareholders
Materiality
high
high

Redemption risk

Shareholder redemptions can materially reduce cash available for an acquisition.

Scope
Trust account and deal financing
Materiality
high
high

Financing risk

The company may need sponsor or third-party funding to meet working capital needs.

Scope
Operating liquidity
Materiality
high
high

Transaction execution risk

A target may not be found, negotiated, approved, or closed on acceptable terms.

Scope
Acquisition process
Materiality
high
medium

Accounting and valuation risk

Warrants and redeemable shares require fair-value and classification judgments.

Scope
Financial statements
Materiality
medium
Warrant instruments
Can change reported equity, liabilities, and earnings volatility
Class A redeemable share classification
Affects balance sheet structure and shareholder equity
Trust account interest income
Drives reported net income despite no operating business
Going-concern assessment
Can influence disclosure and liquidity presentation

ACHIEVE LIFE SCIENCES, INC.

ACHV · In Vitro & In Vivo Diagnostic Substances

HARVARD BIOSCIENCE INC

HBIO · Laboratory Analytical Instruments

Oaktree Specialty Lending Corp

OCSL

ASPAC III Acquisition Corp.

ASPC · Blank Checks

Valuence Merger Corp. I

VMCAF · Blank Checks

INNOVATIVE INDUSTRIAL PROPERTIES INC

IIPR · Real Estate

: 29.4.2026